Differentiating Antipsychotics: An Overview of Properties Impacting Drug Selection - Y8009


About Course #Y8009

Start Date: September 16, 2016

Expiration Date: September 15, 2019

New antipsychotic agents are constantly under development, and the ways in which antipsychotic medications are used in clinical practice continue to change. As new information becomes available, there are new indications, safety warnings, monitoring recommendations, and dosage formulations. It is important that healthcare providers stay abreast of these new developments to optimize treatment. In addition, many antipsychotics have labeled indications for treatment of other mental illnesses, such as major depressive disorder and bipolar disorder, as well as many off-label uses.

This course provides current, evidence-based information on the mechanisms of action, pharmacokinetic and pharmacodynamic parameters, adverse events, adverse event management strategies, clinical indications, and special considerations regarding antipsychotic use. Pharmacists practicing in all settings may encounter patients taking antipsychotic medications or be involved in initiating and/or monitoring treatment with antipsychotics.

Universal Activity Number (UAN) - 0607-0000-16-007-H01-P

Type of Activity - Knowledge

Topic Designator - 01 - Disease State Management/Drug Therapy

Course Objectives

  • Define major theories of the pathophysiology of schizophrenia and psychosis.
  • Describe the mechanism of action of both typical and atypical antipsychotic medications.
  • Identify the multiple indications for typical and atypical antipsychotic use.
  • Identify potential adverse events and implement monitoring parameters for typical and atypical antipsychotic medications.
  • Describe pharmacokinetic and pharmacodynamic parameters of typical and atypical antipsychotic medications that may impact medication selection.
  • Design and recommend an individualized treatment plan for a patient with schizophrenia.

About the Author

Corey E. Scheer, RPh, BS Pharm, PharmD, BCPP, completed her BS Pharm and Doctor of Pharmacy degrees at the University of Connecticut and then went on to complete a postgraduate year 1 residency at the University of Rochester Medical Center in Rochester, NY. From there, she completed a postgraduate year 2 residency specializing in psychiatric pharmacy at the Tuscaloosa VA Medical Center in Tuscaloosa, AL.

Course Disclosures

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
  • bvseo_sdk, p_sdk, 3.2.0
  • CLOUD, getContent, 85.18ms
  • bvseo-msg: HTTP status code of 404 was returned;